Daily Dose

Article

Your daily dose of clinical tips and quips: Histiocytic.

Untitled Document

“Although originating from a common precursor, the benign and malignant counterparts of the histiocytic disease spectrum are vastly different in biologic behavior, recommended treatment, and prognosis. Recognizing the breed and age predilections for this spectrum of clinical diseases is paramount to identifying cases that require a diagnostic work-up.”

-Rebecca E. Risbon, VMD; Craig A. Clifford, DVM, MS, DACVIM (oncology); and Katherine Skorupski, DVM, DACVIM (oncology)

From An overview of canine histiocytic disorders

 

 

Newsletter

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.